Endpoints News 生物医药· Lei Lei Wu·· 2026-10-19AI 评分56
Disc Medicine 治疗罕见光过敏药物的 III 期临床试验在所有终点均取得成功
Disc Medicine reports 'sun allergy' drug hits Phase 3 home run
AI 导读
Disc Medicine 治疗使阳光照射产生疼痛的罕见疾病的药物在 III 期研究的所有终点均取得成功。
正文
Disc Medicine’s treatment for a rare disease that makes sun exposure painful succeeded on all endpoints in a Phase 3 study. The result sets the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news